I agree that this site is using cookies. You can find further informations here.
X
Nissinen, Tuuli A.
43  results:
Search for persons X
?
1

Estrogen deficiency reduces maximal running capacity and af..:

Lee, Earric ; Nissinen, Tuuli A. ; Ylä-Outinen, Laura...
Frontiers in Neuroscience.  18 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Mechanisms Leading to Increased Insulin-Stimulated Cerebral..:

Jalo, Anna ; Helin, Jatta S. ; Hentilä, Jaakko...
Journal of Functional Morphology and Kinesiology.  9 (2024)  2 - p. 58 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Segmentation of Dynamic Total-Body [18F]-FDG PET Images Usi..:

Jaakkola, Maria K. ; Rantala, Maria ; Jalo, Anna...
International Journal of Biomedical Imaging.  2023 (2023)  - p. 1-13 , 2023
Link: https://doi.org/10.1155/..
 
?
4

Targeting the Activin Receptor Signaling to Counteract the ..:

Hulmi, Juha J. ; Nissinen, Tuuli A. ; Penna, Fabio.
Cells.  10 (2021)  3 - p. 516 , 2021
Link: https://doi.org/10.3390/..
 
?
5

Muscle follistatin gene delivery increases muscle protein s..:

Nissinen, Tuuli A. ; Hentilä, Jaakko ; Fachada, Vasco...
The FASEB Journal.  35 (2021)  3 - p. , 2021
Link: https://doi.org/10.1096/..
 
?
6

Activin Receptor Ligand Blocking and Cancer Have Distinct E..:

Hentilä, Jaakko ; Nissinen, Tuuli A. ; Korkmaz, Ayhan...
Frontiers in Physiology.  9 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
7

Blocking Activin Receptor Ligands Is Not Sufficient to Resc..:

Pekkala, Satu ; Keskitalo, Anniina ; Kettunen, Emilia...
Cancers.  11 (2019)  11 - p. 1799 , 2019
Link: https://doi.org/10.3390/..
 
?
8

Treating cachexia using soluble ACVR2B improves survival, a..:

Nissinen, Tuuli A. ; Hentilä, Jaakko ; Penna, Fabio...
Journal of Cachexia, Sarcopenia and Muscle.  9 (2018)  3 - p. 514-529 , 2018
Link: https://doi.org/10.1002/..
 
?
9

Prevention of chemotherapy‐induced cachexia by ACVR2B ligan..:

Hulmi, Juha J. ; Nissinen, Tuuli A. ; Räsänen, Markus...
Journal of Cachexia, Sarcopenia and Muscle.  9 (2017)  2 - p. 417-432 , 2017
Link: https://doi.org/10.1002/..
 
?
10

VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxi..:

Räsänen, Markus ; Degerman, Joni ; Nissinen, Tuuli A....
Proceedings of the National Academy of Sciences of the United States of America.  113 (2016)  46 - p. 13144-13149 , 2016
Link: https://www.jstor.org/st..
 
?
11

VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxi..:

Räsänen, Markus ; Degerman, Joni ; Nissinen, Tuuli A....
Proceedings of the National Academy of Sciences.  113 (2016)  46 - p. 13144-13149 , 2016
Link: https://doi.org/10.1073/..
 
?
12

Mid-infrared supercontinuum generation for spectroscopic ap..:

Nissinen, Tuuli
https://trepo.tuni.fi/handle/10024/140079.  , 2022
Link: https://trepo.tuni.fi/ha..
 
?
13

Muscle follistatin gene delivery increases muscle protein s..:

Nissinen, Tuuli A ; Hentilä, Jaakko ; Fachada, Vasco...
FASEB Journal.  , 2021
Link: http://urn.fi/URN:NBN:fi..
 
?
14

Muscle follistatin gene delivery increases muscle protein s..:

Nissinen, Tuuli A ; Hentila, Jaakko ; Fachada, Vasco...
10.1096/fj.202002008R.  , 2021
Link: http://hdl.handle.net/10..
 
?
15

Targeting the Activin Receptor Signaling to Counteract the ..:

Hulmi, Juha J ; Nissinen, Tuuli A ; Penna, Fabio.
Cells.  , 2021
Link: http://urn.fi/URN:NBN:fi..
 
1-15